ATA ACTION APPLAUDS FDA’S FINAL PDURS GUIDANCE, RECOGNIZING STANDALONE SOFTWARE’S ROLE IN IMPROVING DRUG THERAPY AND PUTS PATIENTS AT THE CENTER OF DIGITAL HEALTH INNOVATION

Final guidance reflects many of the priorities ATA Action has advanced for years, including recognition of standalone software and clinical benefit as a path to FDA-required labeling WASHINGTON, DC, OCTOBER 20, 2026 – ATA Action: Advocacy Shaping Virtual Care, the...